Effect of Lower Extremity Modified Constraint-induced Movement Therapy on Locomotion in Children With Hemiplegia
2026年7月2日 更新者：Mohamed Ali Elsayed Taha、Cairo University
- To determine the effect of modified constraint-induced movement therapy on spatial and temporal gait parameters in children with hemiplegia.
- To determine the effect of modified constraint-induced movement therapy on functional mobility in children with hemiplegia.
研究概览
地位
招聘中
条件
详细说明
Children with spastic hemiplegic cerebral palsy experience longer gait cycles, slower walking speeds, and longer support phases compared to healthy children, with substantial joint angle differences noted during ground contact and stride buffering.
Although most can achieve independent walking, they often exhibit poor motor coordination, resulting in short strides and high stride frequencies for speed maintenance.
Modified constraint-induced movement therapy has been employed to enhance lower-extremity function, but its effectiveness on key ambulation aspects like gait speed and balance remains unclear.
The reliance on the unaffected limb further impacts locomotive behavior, leading to stiff knee gait and reduced functional mobility.
This study aims to explore the therapy's effects on locomotion in hemiplegic children.
研究类型
介入性
注册 (估计的)
30
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
学习联系方式
- 姓名：Mohamed Ali Taha
- 电话号码：01022599920
- 邮箱：dr.mo7amed.ali224@gmail.com
学习地点
-
-
-
Cairo、埃及
- 招聘中
- outpatient clinic faculty of physical therapy, Cairo University
-
接触：
- Mohamed Ali Taha
- 电话号码：01022599920
- 邮箱：dr.mo7amed.ali224@gmail.com
-
-
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 孩子
接受健康志愿者
不
描述
Inclusion Criteria:
- The age of the selected children will range from 6 to 8 years old.
- Degree of spasticity will range from 1+ to 2 according to the modified Ashworth scale.
- The level of motor function of the children will be levels I-II according to the Gross Motor Function Classification System.
- Participants will present a score between 41 to 56 points on the pediatric balance scale.
- They will be able to follow instructions and understand commands.
Exclusion Criteria:
- Bone and tendon lengthening surgeries within the last 6 months.
- Lung and heart diseases and disorders.
- Vision or hearing problems.
- Children with fixed deformities in the lower extremity.
- Children with epilepsy.
- Recent intramuscular Botulinum toxin injection.
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Modified constraint induced movement therapy
Fifteen children will receive a conventional physical therapy program for 1 hour and modified constraint-induced movement therapy for 30 minutes 3 times per week for 4 weeks.
|
Three tasks will be designed to be performed for 10 min each while using the knee scooter as a method of constraint-induced movement therapy The 3 tasks will be as follows:
|
|
有源比较器：Conventional physical therapy
Fifteen children will receive conventional physical therapy program only for 1 hour 3 times per week for 4 weeks.
|
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
assessment of spatial gait parameters
大体时间：At baseline and after Four weeks
|
Kinovea is a free 2D motion analysis software that facilitates inexpensive, sensor-free video-based motion assessments suitable for clinical practice.
Its reliability has been established for measuring cervical range of motion (ROM) in both sagittal and frontal planes, dominant wrist joint ROM, shoulder ROM, and ankle joint ROM during walking.
Additionally, it effectively measures spatial gait parameters, including stride length, step length, and hip, knee, and ankle angles at initial contact and mid-swing stages of the gait cycle.
Required tools for its use include a walking area, digital camera, adhesive skin marks, and a tripod.
|
At baseline and after Four weeks
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
assessment of Temporal gait parameters
大体时间：At baseline and after four weeks
|
Kinovea is a free 2D motion analysis software that utilizes inexpensive, sensor-free video-based techniques for clinical motion analysis.
Its reliability is essential for assessing important psychometric properties, especially in measuring various range of motion (ROM) for cervical, shoulder, and ankle joints, as well as capturing gait parameters like stance and swing phases.
Required tools for its use include a walking area, digital camera, adhesive skin marks, and a tripod.
|
At baseline and after four weeks
|
|
assessment of the functional mobility
大体时间：At baseline and after four weeks
|
The Gross Motor Function Measure (GMFM-88) is a reliable and valid assessment tool for measuring gross motor function in children with cerebral palsy, specifically focusing on standing (segment D) and walking/running (segment E).
It is widely used in clinical and research settings to track changes over time or assess the impact of interventions.
Due to its lengthy administration time, it is best used for annual or biannual evaluations or research studies, and testers should be well-versed in its use prior to administration.
|
At baseline and after four weeks
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2026年6月1日
初级完成 (估计的)
2026年7月30日
研究完成 (估计的)
2026年8月30日
研究注册日期
首次提交
2026年5月29日
首先提交符合 QC 标准的
2026年7月2日
首次发布 (实际的)
2026年7月7日
研究记录更新
最后更新发布 (实际的)
2026年7月7日
上次提交的符合 QC 标准的更新
2026年7月2日
最后验证
2026年7月1日
更多信息
与本研究相关的术语
其他研究编号
- Mohamed Ali-PhD
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.